Future Prospects of Global Personalized Medicine Market 2012-2016

NEW YORK, July 23, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Future Prospects of Global Personalized Medicine Market 2012-2016                                   
http://www.reportlinker.com/p01556751/Future-Prospects-of-Global-Personalized-Medicine-Market-2012-2016.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy

TechNavio's analysts forecast the Global Personalized Medicine market 2012-2016 to grow at a CAGR of 12.07 percent over the period 2012-2016. One of the key factors contributing to this market growth is the significant growth of the Targeted Biologics segment. The Global Personalized Medicine market has also been witnessing an increase in the number of mergers ad acquisitions. However, the low awareness of personalized medicine in developing countries could pose a challenge to the growth of this market.
TechNavio's report, the Future Prospects of Global Personalized Medicine Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Personalized Medicine market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this space include Abbott Laboratories, AstraZeneca plc, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., and Sanofi S.A.
The other vendors mentioned in the report are Affymetrix Inc., Agendia B.V., Agilent Technologies Inc., Amgen Inc., Astellas Pharma Inc., Baxter International Inc., Bayer AG, BG Medicine Inc., Biocartis S.A, Biogen Idec Inc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb Co., Celgene Corp., Daiichi Sankyo Co. Ltd., Danaher Corp., Eli Lilly and Co., Evotec AG, GE Healthcare Ltd., Genelex Corp., GlaxoSmithKline plc, Hologic Inc., Johnson & Johnson, Laboratory Corporation of America Holdings, Life Technologies Corp., Merck KGaA, Mitsubishi Tanabe Pharma Corp., Myriad Genetics Inc., Novartis AG, PerkinElmer Inc., Pfizer Inc., Quest Diagnostics Inc., Sanofi S.A., Siemens Healthcare, Sigma-Aldrich Corp., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Thermo Fisher Scientific Inc., and Transgenomic Inc.

Key questions answered in this report:

What will the market size be in 2016 and what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?

01. Executive Summary
02. List of Abbreviations
03. Introduction
04. Market Research Methodology
Market Research Process
Research Design
Research Methodology
05. Scope of the Report
Market Overview
Product Offerings
06. Market Landscape
06.1 Market Size and Forecast
06.2 Key Market Segmentation
Segmentation by Product Types
Global Targeted Biologics Market
Global Proteomics and Genomics Market
Segmentation by Application Technologies
06.3 Five Forces Analysis
07. Geographical Segmentation
08. Key Leading Countries
USA
Germany
Japan
09. Vendor Landscape
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Key Vendor Analysis
16.1 Abbott Laboratories
Business Overview
Key Information
SWOT Analysis
16.2 AstraZeneca plc
Business Overview
Key Information
SWOT Analysis
16.3 F. Hoffmann-La Roche Ltd.
Business Overview
Key Information
SWOT Analysis
16.4 Novartis AG
Business Overview
Key Information
SWOT Analysis
16.5 Pfizer Inc.
Business Overview
Key Information
SWOT Analysis
16.6 Sanofi S.A.
Business Overview
Key Information
SWOT Analysis
17. Other Reports in this Series

List of Exhibits

Exhibit 1: Market Research Methodology
Exhibit 2: Global Personalized Medicine Market 2012-2016 (US$ billion)
Exhibit 3: Major Products and Indications in the Global Personalized Medicine Market
Exhibit 4: Global Personalized Medicine Market by Product Types
Exhibit 5: Global Targeted Biologics Market 2012-2016 (US$ billion)
Exhibit 6: Global Proteomics and Genomics Market 2012-2016 (US$ billion)
Exhibit 7: Global Personalized Medicine Market by Application Technologies
Exhibit 8: Global Personalized Medicine Market by Geographical Segmentation 2012
Exhibit 9: Business Segmentation of Abbott Laboratories
Exhibit 10: Business Segmentation of AstraZeneca plc
Exhibit 11: Business Segmentation of Hoffmann-La Roche Ltd.
Exhibit 12: Business Segmentation of Novartis AG
Exhibit 13: Business Segmentation of Pfizer Inc.
Exhibit 14: Business Segmentation of Sanofi S.A.

Companies Mentioned

Abbott Laboratories, AstraZeneca plc, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Sanofi S.A., Affymetrix Inc., Agendia B.V., Agilent Technologies Inc., Amgen Inc., Astellas Pharma Inc., Baxter International Inc., Bayer AG, BG Medicine Inc., Biocartis S.A, Biogen Idec Inc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb Co., Celgene Corp., Daiichi Sankyo Co. Ltd., Danaher Corp., Eli Lilly and Co., Evotec AG, GE Healthcare Ltd., Genelex Corp., GlaxoSmithKline plc, Hologic Inc., Johnson & Johnson, Laboratory Corporation of America Holdings, Life Technologies Corp., Merck KGaA, Mitsubishi Tanabe Pharma Corp., Myriad Genetics Inc., Novartis AG, PerkinElmer Inc., Pfizer Inc., Quest Diagnostics Inc., Sanofi S.A., Siemens Healthcare, Sigma-Aldrich Corp., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Thermo Fisher Scientific Inc., and Transgenomic Inc.

To order this report:
Therapy Industry: Future Prospects of Global Personalized Medicine Market 2012-2016                                   

Contact Clare: [email protected]  
US:(339) 368 6001
Intl:+1 339 368 6001

SOURCE Reportlinker